Trial NCT03502577

View at ClinicalTrials.gov 
Org. Study IDs: 9952
Secondary IDs: 9952 NCI-2018-00514 RG9218033

Last trial update was posted on 2024-01-08

MeSH Interventions

Cyclophosphamide Fludarabine Gamma Secretase Inhibitors and Modulators

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Stopping Reasons

Closed per SRC Low Accrual Policy

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID